SEATTLE (AP) _ Immune Design Corp. (IMDZ) on Tuesday reported a loss of $14.4 million in its fourth quarter.
On a per-share basis, the Seattle-based company said it had a loss of 57 cents.
The results met Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for a loss of 57 cents per share.
The biotechnology company posted revenue of $2.1 million in the period.
For the year, the company reported that its loss widened to $53.5 million, or $2.47 per share. Revenue was reported as $13.3 million.
Immune Design shares have declined slightly more than 7 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $5.10, a fall of 61 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IMDZ at https://www.zacks.com/ap/IMDZ
Keywords: Immune Design, Earnings Report